Invention Grant
US08951529B2 Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
有权
使用小化合物增强骨髓来源的抑制细胞功能治疗自身免疫性疾病的方法
- Patent Title: Methods of using small compounds to enhance myeloid derived suppressor cell function for treating autoimmune diseases
- Patent Title (中): 使用小化合物增强骨髓来源的抑制细胞功能治疗自身免疫性疾病的方法
-
Application No.: US13518513Application Date: 2010-12-21
-
Publication No.: US08951529B2Publication Date: 2015-02-10
- Inventor: Shu-Hsia Chen
- Applicant: Shu-Hsia Chen
- Applicant Address: US NY New York
- Assignee: Icahn School of Medicine at Mount Sinai
- Current Assignee: Icahn School of Medicine at Mount Sinai
- Current Assignee Address: US NY New York
- Agency: Fish & Richardson P.C.
- International Application: PCT/US2010/061610 WO 20101221
- International Announcement: WO2011/087795 WO 20110721
- Main IPC: A61K38/02
- IPC: A61K38/02 ; A61K35/14 ; A61K31/137 ; A61K31/395 ; A61K31/416 ; A61K31/465 ; A61K38/18 ; A61K38/19

Abstract:
Methods for enhancing the suppressive function of myeloid derived suppressor cells (MDSCs) for the treatment of autoimmune diseases using small compounds are disclosed. In certain aspects, the small compounds are glatiramer acetate and mitogen activated protein (MAP) kinase inhibitors. In other aspects, these methods include the administration of exogenous MDSCs or the use of endogenous MDSCs mobilized using stem cell mobilizers. In yet other aspects, compositions containing MDSCs and small compounds of the invention are provided.
Public/Granted literature
Information query
IPC分类: